Aemetis (AMTX) Return on Sales (2016 - 2025)
Historic Return on Sales for Aemetis (AMTX) over the last 13 years, with Q3 2025 value amounting to 0.4%.
- Aemetis' Return on Sales fell 1800.0% to 0.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.35% for FY2024, which is 600.0% down from last year.
- Aemetis' Return on Sales amounted to 0.4% in Q3 2025, which was down 1800.0% from 0.45% recorded in Q2 2025.
- In the past 5 years, Aemetis' Return on Sales ranged from a high of 0.45% in Q3 2023 and a low of 12.28% during Q1 2023
- Moreover, its 5-year median value for Return on Sales was 0.42% (2021), whereas its average is 0.97%.
- In the last 5 years, Aemetis' Return on Sales plummeted by -119300bps in 2023 and then surged by 119400bps in 2024.
- Aemetis' Return on Sales (Quarter) stood at 0.01% in 2021, then plummeted by -3038bps to 0.43% in 2022, then fell by -7bps to 0.46% in 2023, then fell by -2bps to 0.47% in 2024, then rose by 14bps to 0.4% in 2025.
- Its Return on Sales stands at 0.4% for Q3 2025, versus 0.45% for Q2 2025 and 0.57% for Q1 2025.